Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Stichting Hemato-Oncologie voor Volwassenen Nederland
Stichting Hemato-Oncologie voor Volwassenen Nederland
Daiichi Sankyo
Institute of Hematology & Blood Diseases Hospital, China
The First Affiliated Hospital of Soochow University
Institute of Hematology & Blood Diseases Hospital, China
Delta-Fly Pharma, Inc.
Goethe University
Astellas Pharma Inc
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Sunshine Lake Pharma Co., Ltd.
Technische Universität Dresden
Gilead Sciences
The First Affiliated Hospital of Soochow University
Daiichi Sankyo
University of Ulm
Eastern Cooperative Oncology Group
Janssen Research & Development, LLC
University Hospital Tuebingen
Children's Oncology Group
Gruppo Italiano Malattie EMatologiche dell'Adulto
Polish Adult Leukemia Group
The First Affiliated Hospital of Soochow University
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Ulm
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Cooperative Study Group A for Hematology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Ulm